Virtu Financial LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 70 filers reported holding CASI PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$91,000
+40.0%
112,777
+39.6%
0.01%0.0%
Q4 2021$65,000
+80.6%
80,806
+164.4%
0.01%
+133.3%
Q3 2021$36,000
-77.4%
30,560
-53.8%
0.00%
-72.7%
Q1 2021$159,000
+329.7%
66,106
+431.0%
0.01%
+175.0%
Q4 2020$37,000
-37.3%
12,450
-67.7%
0.00%
-60.0%
Q3 2020$59,000
+51.3%
38,496
+217.5%
0.01%
+400.0%
Q4 2017$39,000
-45.8%
12,124
-70.3%
0.00%
-50.0%
Q3 2017$72,00040,7900.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 896,137$4,185,0002.27%
Wellington Shields Capital Management, LLC 888,333$4,149,0000.67%
Manatuck Hill Partners, LLC 15,090$70,0000.03%
IHT Wealth Management, LLC 10,725$50,0000.01%
Perceptive Advisors 43,682$204,0000.01%
ALPS ADVISORS INC 153,234$716,0000.01%
ROYCE & ASSOCIATES LP 78,742$368,0000.00%
MEEDER ASSET MANAGEMENT INC 5,863$28,0000.00%
Tower Research Capital LLC (TRC) 5,974$28,0000.00%
METROPOLITAN LIFE INSURANCE CO/NY 18,585$86,7920.00%
View complete list of CASI PHARMACEUTICALS INC shareholders